Higher drug discovery failure rate has led to an increase in drug prises in the market. BioInteract technique is designed to combat the failure rate by identifying most potential therapeutic drug for a broad range of genetic diseases by analysing the drug effect at molecular level. It is a scoring system that can rank drugs based on their ability to restore the key interactors at the molecular level in the mutant cell and thus predict how successful a drug will be in the given disease.
Join a thriving innovation ecosystem. Subscribe now